NCT07440901 2026-02-27
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
Clinical Trials
9 trialsNCT05863052 2026-02-10
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
Active not recruiting
NCT06583070 2026-01-28
COSTAR
Peking University First Hospital
Recruiting
NCT06120374 2025-12-30
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
Recruiting
NCT07250542 2025-11-26
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
Zhongda Hospital
Phase 2 Recruiting
NCT06798246 2025-01-29
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study
Peking University First Hospital
Not yet recruiting
NCT05229614 2024-08-21
ICONIC
CNAO National Center of Oncological Hadrontherapy
Phase 2 Recruiting
NCT03115801 2021-09-22
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
Weill Medical College of Cornell University
Phase 2 Terminated
NCT00610389 2010-05-10
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
Clinica Universidad de Navarra, Universidad de Navarra
Phase 2 Unknown